[ESPR] YoY Quarter Result on 31-Dec-2013 [#Q4]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
13-Mar-2014
Financial Year
2013
Quarter
31-Dec-2013 [#Q4]
Profit Trend
QoQ- -84.98%
YoY- -249.15%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/02 31/12/01 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -28,956 -13,122 -9,457 -9,689 -2,775 -6,619 -6,344 10.64%
Tax 423 287 135 47 476 692 -112 -
NP -28,956 -13,122 -9,457 -9,689 -2,775 -6,619 -6,344 10.64%
Tax Rate - - - - - - - -
Total Cost 28,956 13,122 9,457 9,689 2,775 6,619 6,344 10.64%
Ratio Analysis
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/02 31/12/01 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/02 31/12/01 CAGR
EPS -1.28 -0.58 -0.49 -0.63 -0.29 -1.58 -1.57 -1.35%
EPS Diluted -1.28 -0.58 -0.49 -0.63 -0.29 -1.58 -1.57 -1.35%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.